Tag: HTA

How Do You Value a “Cure” in Healthcare?

Panel Explores Questions Around How to Best Assess “Value” for Curative Therapies Entering the Market  Barcelona, Spain—13 November 2018—ISPOR, the professional society for health economics and outcomes research, held a spotlight session this afternoon at ISPOR Europe 2018, “Valuing a

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

What Impact Will European Commission’s Draft Regulation on HTA Have on Decision Makers in the European Union?

Panel Debates Proposed Europe-Wide Introduction of a Joint Health Technology Assessment  Barcelona, Spain—12 November 2018—ISPOR, the professional society for health economics and outcomes research, opened ISPOR Europe 2018 this morning with its first plenary, “Joint Assessment of Relative Effectiveness: ‘Trick or

Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR Launches Center for Health Technology Assessment

www,HTAcenter.org

New Website Offers Comprehensive Repository of Resources and Tools Lawrenceville, NJ, USA—May 14, 2018—ISPOR, the professional society for health economics and outcomes research (HEOR), announced today the launch of its new Center for Health Technology Assessment website. The new website

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

High-Risk Medical Devices Granted European Licensure Based on Low-Quality Evidence

Value in Health Report Strongly Recommends Enforcing a Requirement of High-Quality Studies for Demonstrating Clinical Efficacy and Safety   Lawrenceville, NJ—January 2, 2018—Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today

Posted in Announcements, ISPOR Journals, ISPOR News & Press, Value in Health Tagged with: , ,

ISPOR 20th Annual European Congress Examines the Real Value in Health Care

Nearly 5000 Health Care Stakeholders Convened in Glasgow, Scotland Glasgow, Scotland, UK—9 November 2017—ISPOR, the professional society for health economics and outcomes research (HEOR), recently concluded its 20th Annual European Congress in Glasgow, Scotland, UK. The congress was held 4-8

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

What Is the Future of Health Technology Assessment in Europe?

Glasgow, Scotland, UK—7 November 2017—ISPOR, the professional society for health economics and outcomes research (HEOR), held the second plenary session, “Appraising the Appraisers: What Is the Future of Health Technology Assessment in Europe?” this morning at its 20th Annual European

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

How Can Good Research Practice Guidance Improve Health Technology Assessment?

Glasgow, Scotland, UK—6 November 2017—ISPOR, the professional society for health economics and outcomes research (HEOR), focused on what aspects of health technology assessment (HTA) can be improved with good research practice guidance. The workshop, “Where Do We Need Good Research

Posted in Announcements, ISPOR News & Press Tagged with: , ,

ISPOR’s 20th Annual European Congress to Focus on the Evolution of Value in Health Care

Congress to Be Held 4-8 November 2017 in Glasgow, Scotland, UK Princeton, NJ, USA—30 October 2017—ISPOR, the professional society for health economics and outcomes research (HEOR), released the final program and speakers for its upcoming 20th Annual European Congress scheduled

Posted in Announcements, ISPOR News & Press Tagged with: , , , ,

Plenary Sessions and Speakers Announced for ISPOR 20th Annual European Congress

Conference to Explore The Evolution of Value in Health Care on 4-8 November 2017 in Glasgow, Scotland Princeton, NJ—September 18, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) announced plenary sessions and speakers for its 20th Annual European Congress

Posted in Announcements, ISPOR News & Press Tagged with: , , ,

What Can We Learn From Global Health Care Systems?

A Look at Health Care Systems from Around the World Boston, MA—May 23, 2017—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held a number of sessions at its 22nd Annual International Conference in Boston, MA, USA that focused on

Posted in Announcements, ISPOR News & Press Tagged with: , , ,